KRT18 and metabolic dysfunction-associated steatotic liver disease: In one study cytokeratin-18 fragment level is introduced as noninvasive biomarker for NAFLD while in the other investigation a large number of biomarkers are tabulated and introduced to diagnose NAFLD (9, 10).